Showing 51 – 60 of 646 results
Trading Tools | Charles Schwab
Learn about specialized tools traders may use to make trading decisions.
Liz Ann Sonders | Charles Schwab
Liz Ann Sonders is Managing Director and Chief Investment Strategist at Charles Schwab. She has a range of investment strategy responsibilities, from market and economic analysis to investor education, all focused on the individual investor. She cohosts Schwab's I podcast.
How Do You Plan for the Succession of a Business? | Charles Schwab
Austin Jarvis joins Mark Riepe to discuss succession planning for business owners and the unique challenges faced when keeping a business in the family or selling to a third party.
Schwab Market Update | Charles Schwab
Essential information for investors to start their days, including a summary of market news, stocks to watch, and a look at what's ahead.
How Tomorrow Feels Today | Charles Schwab
Whether expecting joy or despair, we tend to overestimate the long-term emotional impact of life events.
Edgy Investors Waiting to See How Policies Unfold | Charles Schwab
Investors and markets are anxious to see when and how the new Congress will implement the massive Republican policy agenda. But the details matter, and the answers will take time.
About the Author | Charles Schwab
Buy from Amazon Buy from Barnes & Noble Buy from BAM! Buy from Apple Books Buy from Indie BoundBuy from Amazon Buy from Barnes & Noble Buy from BAM! Buy from Apple Books Buy from Indie Bound ThisInsurance iBooks is a registered trademark of Apple Inc. Amazon and all related logos are trademarks of Amazon.com, Inc. or its affiliates....
Before the Rate Cut, Our View of the Markets | Charles Schwab
Now that the yield curve has uninverted, what can we expect from the markets as we approach next week's Fed meeting?
Behavioral Finance | Charles Schwab
Discover how psychological influences and biases may affect your financial behavior.
Markets and Economy | Charles Schwab
Read our latest market commentary on of-the-moment trends so you can make informed investment decisions